Vallejo-Vaz, A. J., Leiter, L. A., Del Prato, S., Taskinen, M., Müller-Wieland, D., Bujas-Bobanovic, M., . . . Ray, K. K. (2020). Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab. Eur J Prev Cardiol.
Chicago-стиль цитированияVallejo-Vaz, Antonio J., et al. "Triglyceride Concentrations and Non-high-density Lipoprotein Cholesterol Goal Attainment in the ODYSSEY Phase 3 Trials With Alirocumab." Eur J Prev Cardiol 2020.
MLA-цитированиеVallejo-Vaz, Antonio J., et al. "Triglyceride Concentrations and Non-high-density Lipoprotein Cholesterol Goal Attainment in the ODYSSEY Phase 3 Trials With Alirocumab." Eur J Prev Cardiol 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.